Search results for "Kinetics"

showing 10 items of 2224 documents

Pharmacokinetic Study on Adenomatous Prostate Tissue Concentrations of Cef operazone

1989

Cephalosporins do not reach active therapeutical concentrations in the prostatic tissue in patients suffering from chronic bacterial prostatitis. Cefoperazone is an exception. Its efficacy in the trea

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAntibioticsCephalosporinProstatitisGastroenterologyPharmacokineticsProstateInternal medicineDrug DiscoverymedicinePharmacology (medical)PharmacologyChemotherapybusiness.industryGeneral Medicinemedicine.diseaseCefoperazoneInfectious Diseasesmedicine.anatomical_structureChronic bacterial prostatitisOncologyImmunologybusinessmedicine.drugChemotherapy
researchProduct

Effect of Soluble Interleukin-6 Receptor on Interleukin-6 Synthesis in Human Skin Fibroblasts

1996

Abstract In this study the ability of soluble interleukin-6 receptor (sIL-6R) to stimulate interleukin-6 (IL-6) synthesis in human fibroblasts is described. It was found that sIL-6R, in combination with endogenous or exogenous IL-6, markedly upregulated IL-6 synthesis. These data suggest that increased IL-6 production after stimulation by either interleukin-1 or tumor necrosis factor-α would result in complex formation with sIL-6R, rapid uptake, and further synthesis of this cytokine. Furthermore, it would explain the decrease in sIL-6R plasma levels observed in patients suffering from sepsis.

medicine.medical_specialtymedicine.medical_treatmentBiophysicsGene ExpressionHuman skinStimulationEndogenyBiochemistryDownregulation and upregulationAntigens CDInternal medicinemedicineHumansInterleukin 6ReceptorMolecular BiologyCells CulturedSkinbiologyInterleukin-6Receptors InterleukinCell BiologyFibroblastsReceptors Interleukin-6Recombinant ProteinsKineticsCytokineEndocrinologybiology.proteinTumor necrosis factor alphaBiochemical and Biophysical Research Communications
researchProduct

Theoretical approach and clinical application of kinetic modelling in dialysis.

1991

Using kinetic modelling for shaping profile dialysis, we present a promising approach to improve the cardiovascular stability of patients during dialysis treatment. In order to obtain an insight into the physiological mechanisms of increased stability, a model considering alterations of electrolytes and water distribution and of acid-base status was developed. This algorithm was used for the evaluation of 114 dialysis sessions, which were performed with highly individualised profiles. Each profile was developed for one patient by trying empirically to prevent episodes of hypotension as well as other clinical problems throughout dialysis. The main advantage of profile dialysis compared to st…

medicine.medical_specialtymedicine.medical_treatmentFluid shiftModels BiologicalBody WaterRenal DialysisMedicineHumansComputer SimulationIntensive care medicineAgedAcid-Base EquilibriumTransplantationKinetic modelbusiness.industrySodiumMiddle AgedWater-Electrolyte BalanceBicarbonate dialysisKineticsNephrologyHemodialysisHypotensionbusinessDialysis (biochemistry)SoftwareNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Renal Allograft Compartment Syndrome: Is It Possible to Prevent?

2016

Renal allograft compartment syndrome (RACS) is a complication characterized by increased pressure over 15 to 20 mm Hg of the iliac fossa site of transplanted kidney that can lead to a reduction of the blood supply to the graft, resulting in organ ischemia. This study aims to evaluate, through a review of the literature, the incidence, detection, treatment, and possible prevention of RACS. The incidence of this complication, which appears generally in the immediate post-transplantation period, is currently approximately 1% to 2% and is underestimated because of poor nosography for the presence of symptoms common to other post-transplantation complications. Doppler ultrasound is indispensable…

medicine.medical_specialtymedicine.medical_treatmentIschemiaIliac fossa030230 surgeryCompartment SyndromesAbdominal wall03 medical and health sciences0302 clinical medicinePostoperative ComplicationsmedicineHumansCompartment (pharmacokinetics)Reduction (orthopedic surgery)Transplantationbusiness.industryIncidence (epidemiology)Abdominal Wound Closure Techniquesmedicine.diseaseDecompression SurgicalKidney TransplantationSurgery; TransplantationSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureEarly Diagnosis030220 oncology & carcinogenesisRenal allograftSurgeryComplicationbusinessTransplantation proceedings
researchProduct

F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.

2022

Background Circulating dysfunctional factor IX (FIX) might modulate distribution of infused FIX in hemophilia B (HB) patients. Recurrent substitutions at FIX activation sites (R191-R226, >300 patients) are associated with variable FIX activity and antigen (FIXag) levels. Objectives To investigate the (1) expression of a complete panel of missense mutations at FIX activation sites and (2) contribution of F9 genotypes on the FIX pharmacokinetics (PK). Methods We checked FIX activity and antigen and activity assays in plasma and after recombinant expression of FIX variants and performed an analysis of infused FIX PK parameters in patients (n = 30), mostly enrolled in the F9 Genotype and PK HB …

medicine.medical_specialtypharmacogenetics.Mutation MissenseSocio-culturaleAlpha (ethology)aemophilia Brecombinant proteinsHemophilia Blaw.inventionFactor IXAntigenlawInternal medicineGenotypemedicineMissense mutationHumansHaemophilia BpharmacokineticBeta (finance)Factor IXpharmacogeneticsChemistryHematologymedicine.diseaseEndocrinologyPhenotypefactor IX activation; hemophilia B; pharmacogenetics; pharmacokinetics; recombinant proteinsRecombinant DNAFemalefactor IX activationBlood Coagulation Testspharmacokineticsrecombinant proteinmedicine.drugJournal of thrombosis and haemostasis : JTH
researchProduct

Unusual oxygen binding behavior of a 24-meric crustacean hemocyanin.

2009

Abstract Hemocyanins from Crustacea usually are found as 1 × 6 or 2 × 6-meric assemblies. An exception is the hemocyanin isolated from thalassinidean shrimps where the main component is a 24-meric structure. Our analysis of oxygen binding data of the thalassinidean shrimp Upogebia pusilla based on a three-state MWC-model revealed that despite the 24-meric structure the functional properties can be described very well based on the hexamer as allosteric unit. In contrast to the hemocyanins from other thalassinidean shrimps the oxygen affinity of hemocyanin from U. pusilla is increased upon addition of l -lactate. A particular feature of this hemocyanin seems to be that l -lactate already enha…

medicine.medical_treatmentAllosteric regulationBiophysicschemical and pharmacologic phenomenaCooperativityRandom hexamerHemocyaninBiochemistryOxygen bindingAllosteric RegulationCrustaceaDecapodamedicineAnimalsHemocyanin; Crustacea; Allosteric model; Kinetics; Oxygen bindingMolecular BiologybiologyEcologyfungiHemocyaninbiology.organism_classificationAllosteric modelCrustaceanShrimpOxygenKineticsHemocyaninsBiophysicsLimiting oxygen concentrationOxygen bindingProtein BindingArchives of biochemistry and biophysics
researchProduct

Enantioselective determination of plasma protein binding of common amphetamine-type stimulants.

2021

Amphetamine-type stimulants (ATS) like amphetamine ('speed'), methamphetamine ('crystal meth') and 3,4-methylenedioxy-N-methylamphetamine (MDMA, 'ecstasy') represent some of the most frequently abused drugs worldwide. Another less frequently abused ATS is 4-fluoroamphetamine (4-FA). The enantiomers of these four compounds exhibit different pharmacokinetic and pharmacodynamic properties. According to the free drug theory, the pharmacological properties of a substance are dependent on its plasma protein binding (PPB). However, data on PPB of stimulant enantiomers in humans are rare or non-existent. Human plasma samples were spiked with racemic mixtures of the stimulants and subjected to ultra…

medicine.medical_treatmentClinical BiochemistryPharmaceutical ScienceTandem mass spectrometryAnalytical ChemistryPharmacokineticsTandem Mass SpectrometryDrug DiscoverymedicineHumansAmphetamineSpectroscopyChromatographyChemistryIllicit DrugsForensic toxicologyMDMAStereoisomerismMethamphetamineStimulantAmphetamineCentral Nervous System StimulantsEnantiomermedicine.drugChromatography LiquidProtein BindingJournal of pharmaceutical and biomedical analysis
researchProduct

Growth factors and cell kinetics: a mathematical model applied to Il-3 deprivation on leukemic cell lines.

1992

We assume the existence of a specific G1 protein which is an initiator of DNA replication. This initiator is supposed to be synthesized according to Michaelis-Menten kinetics. In order to start DNA replication, it is assumed that this G1 specific protein must be produced in a required amount. Intra-cellular growth inhibitors and extra-cellular growth factors control the production of the initiator. This model allows to calculate the average G1 phase time as a function of the various chemical concentrations of nutrients, enzymes, growth inhibitors and growth factors. This model is compared to cell kinetics experiments on a leukemic cell line responding to Interleukin 3 deprivation. The curve…

medicine.medical_treatmentKineticsBiologyModels BiologicalGeneral Biochemistry Genetics and Molecular BiologymedicineCells CulturedGeneral Environmental ScienceInterleukin 3chemistry.chemical_classificationLeukemia ExperimentalApplied MathematicsGrowth factorDNA replicationG1 PhaseGeneral MedicineDNACell cyclePhilosophyKineticsEnzymeCytokineBiochemistrychemistryCell cultureBiophysicsInterleukin-3General Agricultural and Biological SciencesActa biotheoretica
researchProduct

Production and characterization of the recombinant Sphingomonas chlorophenolica pentachlorophenol 4-monooxygenase.

2001

Abstract Pentachlorophenol 4-monooxygenase (PCP4MO) from Sphingomonas chlorophenolica is a flavoprotein that hydroxylates PCP in the presence of NADPH and oxygen. In order to investigate the structure and function of active site, recombinant PCP4MO (rePCP4MO) was produced in Escherichia coli as a glutathione S-transferase (GST) fusion protein. Moreover, a tobacco etch virus (TEV) protease cleavage site (EKLYFQG) was introduced into GST-PCP4MO and a his-tagged TEV protease was employed. Hence, a two-step purification protocol was developed which allowed obtaining 15–20 mg of rePCP4MO from 1 L culture. The rePCP4MO revealed identity with native enzyme by SDS–PAGE and N-terminal sequence analy…

medicine.medical_treatmentRecombinant Fusion ProteinsPotyvirusBiophysicsFlavoproteinBiochemistrySphingomonaslaw.inventionMixed Function Oxygenaseschemistry.chemical_compoundAffinity chromatographylawEndopeptidasesTEV proteasemedicineEscherichia coliAmino Acid SequenceMolecular BiologyDNA PrimersProteaseBinding SitesbiologyBase SequenceTobacco etch virusCell BiologySphingomonasbiology.organism_classificationPentachlorophenolKineticschemistryBiochemistrybiology.proteinRecombinant DNABiochemical and biophysical research communications
researchProduct

Kinetic properties of catecholoxidase activity of tarantula hemocyanin

2008

Phenoloxidases occur in almost all organisms, being essentially involved in various processes such as the immune response, wound healing, pigmentation and sclerotization in arthropods. Many hemocyanins are also capable of phenoloxidase activity after activation. Notably, in chelicerates, a phenoloxidase has not been identified in the hemolymph, and thus hemocyanin is assumed to be the physiological phenoloxidase in these animals. Although phenoloxidase activity has been shown for hemocyanin from several chelicerate species, a characterization of the enzymatic properties is still lacking. In this article, the enzymatic properties of activated hemocyanin from the tarantula Eurypelma californi…

medicine.medical_treatmentchemical and pharmacologic phenomenaBiologyBiochemistrySubstrate Specificitychemistry.chemical_compoundDopamineHemolymphmedicineAnimalsMolecular Biologychemistry.chemical_classificationSodium Dodecyl SulfateSubstrate (chemistry)Spidershemic and immune systemsHemocyaninCell BiologyTyramineEnzyme ActivationKineticsEnzymechemistryBiochemistryHemocyaninsAzideKojic acidCatechol Oxidasemedicine.drugThe FEBS Journal
researchProduct